🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
17.58
-0.96 (-5.18%)
At close: Nov 20, 2026, 4:00 PM EST
18.00
+0.42 (2.39%)
After-hours: Nov 20, 2026, 7:30 PM EST

Caris Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
5,0427,612---
Market Cap Growth
-25.23%----
Enterprise Value
4,7377,284---
Last Close Price
17.5826.98---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Forward PE
71.87294.73---
PS Ratio
4.819.37---
PB Ratio
7.8813.19---
P/TBV Ratio
8.1313.64---
P/FCF Ratio
174.39113.80---
P/OCF Ratio
60.1091.54---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
4.528.97---
EV/EBITDA Ratio
29.16107.54---
EV/EBIT Ratio
33.85161.45---
EV/FCF Ratio
163.86108.88---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.720.74-1.53-11.041.08
Debt / EBITDA Ratio
2.675.45---
Debt / FCF Ratio
16.026.39---
Net Debt / Equity Ratio
-0.48-0.64-1.29-4.86-0.55
Net Debt / EBITDA Ratio
-1.87-5.48-1.72-0.350.52
Net Debt / FCF Ratio
-10.53-5.54-1.41-0.320.42
Asset Turnover
0.941.111.090.54-
Inventory Turnover
3.435.255.244.48-
Quick Ratio
5.677.160.931.863.29
Current Ratio
6.727.851.302.553.77
Return on Equity (ROE)
17.19%-45.37%--293.82%-
Return on Assets (ROA)
8.58%-73.22%-99.98%-81.84%-55.73%
Return on Capital Employed (ROCE)
12.80%4.50%-144.20%-100.60%-54.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
1.90%-0.89%---
FCF Yield
0.57%0.88%---
Buyback Yield / Dilution
-177.01%-371.04%-1.59%-4.73%-
SEC Filings: 10-K · 10-Q